TRAXENS
19.9.2018 16:02:11 CEST | Business Wire | Press release
TRAXENS today announced that ERCI Eurail Clusters has named TRAXENS DIGITAL FREIGHT TRAIN, Europe's first Freight Train to use an innovative IoT-based system allowing digitalization of operations, the winner of their « Coup de Cœur » Innovation Award. The prize has been given to the company at the InnoTrans 2018 tradeshow in Berlin.
Initially launched with Fret SNCF, the TRAXENS DIGITAL FREIGHT TRAIN solution is based on smart devices capable of communicating with each other using wireless digital network. TRAXENS solution goes beyond smart wagons to connect the entire train offering new high-value-added services.
Inherited from the Shipping Industry, TRAXENS DIGITAL FREIGHT TRAIN has been designed to work worldwide and manage any type of asset (e.g., Dry or Reefer container, wagon, trailer) which means that rail freight can be connected to the rest of the supplier chain anywhere, to explore and leverage door-to-door multimodal applications.
« This industry recognition is a major milestone for us. We have achieved to design and implement with our partner SNCF Logistics such a solution in a two-year timeframe, which has never been experienced in the industry. We are looking forward to extending the solution worldwide, said Florence Delalande, Rail Business Unit Director at TRAXENS.
Dirk-Ulrich Krüger, Spokesperson of the European Railway Clusters Initiative, comments: « We are thrilled to recognize next-generation innovation in the railway industry, and that’s why TRAXENS has earned this award from ERCI Eurail Clusters. Some of the best solutions, come from these kinds of forward-thinking players who think outside of the box. »
The DIGITAL FREIGHT TRAIN innovation enables the stakeholders of the railway ecosystem to share benefits and costs:
Railway undertakings optimise their wagon fleet and streamline operations.
Shippers geolocate their shipments in real-time anywhere around the world and receive alerts when their shipment arrives at key locations
Wagon keepers can use preventive and predictive maintenance based on hard facts (accurate mileage tracking, information on abnormal shocks, brake and axle monitoring).
Customized services are possible: remote control, door opening, temperature and humidity monitoring.
About ERCI Innovation Awards
The ERCI Innovation Awards recognize companies from ERCI partner clusters that have successfully introduced innovative products or solutions to the market. The prize is initiated by the European Railway Clusters Initiative (ERCI).
The categories of the ERCI Innovation Awards are:
- “Best Large Enterprise”
- “Best SME”
- “Coup de Cœur” special jury prize
The term of the award is annually. Hosting of the award ceremony rotates among the ERCI members. The 2018 awarding ceremony was hosted by the Cluster Transport, Mobility and Logistics Berlin-Brandenburg at InnoTrans 2018 on Wednesday, 19 September 2018.
The awarding ceremony, which took place at the Berlin-Brandenburg joint booth in the CityCube, hall B, on Wednesday, 19 September 2018, was organised by the ERCI partner Cluster Transport, Mobility and Logistics in Berlin and Brandenburg with support from Berlin Partner of Business and Technology. The ERCI Innovation Awards Ceremony took place for the fourth time in 2018:
About ERCI
The European Railway Clusters Initiative was founded in 2010 with the signature of the cooperation treaty on InnoTrans 2010. Member clusters of ERCI are:
- I-Trans competitiveness cluster (Famars, France)
- BTS Rail Saxony (Dresden, Germany)
- Cluster Mobilität, Verkehr und Logistik Berlin-Brandenburg, c/o Berlin Partner for Business and Technology (Berlin, Germany)
- CNA Cluster Bahntechnik Bayern (Nuremberg, Germany)
- DITECFER (Pistoia, Italy)
- Inno-Pro (Karup, Denmark)
- Järnvägsklustret (Västeras, Sweden)
- Logistics in Wallonia (Grace-Hollogne, Belgium)
- The Rail Alliance (Birmingham, UK)
- Railgrup (Barcelona, Spain)
- Southern Railway Cluster (Katowice, Poland)
The 11 partner clusters represent more than 1,000 companies from railway industry from all over Europe. ERCI aims aims to promote innovation and the development of new business opportunities as a means of sustainably bolstering competitiveness within the European railway industry. ERCI fosters collaboration between industry and research, initiates innovation projects and organises B2B meetings and workshops. This also includes the promotion of good visibility and networking at EU level.
Projects with participation of ERCI partner clusters include
-
PERES (Promoting European Rail Excellence outSide EU), an ESCP 4i
partnership under the roof of the European Cluster Collaboration
Platform (ESCP).
More information: http://www.peresinfo.com/ - RECORD (Regions in Europe Coordinate and Optimize innovation and competitiveness policy instruments towards improving the sustainability of transport – study case of SMEs in the railway sector). More information: https://www.interregeurope.eu/record/
About TRAXENS :
TRAXENS delivers the world's most exhaustive, precise and timely information about containers in transit anywhere in the world using breakthrough technology and Big Data techniques. This information provides all stakeholders in multi-modal transport the opportunity to improve costs, optimize investment, and offer premium services.
For more information: www.traxens.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180919005029/en/
Contact:
Press Contact: TRAXENS Geraldine Sauniere, Tel: +33-6-95-91-58-99 Director of Communications g.sauniere@traxens.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
